Sellas Life Common Stock Total Equity Over Time
| SLS Stock | USD 1.13 0.04 3.42% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Sellas Life Performance and Sellas Life Correlation. Sellas |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sellas Life. If investors know Sellas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sellas Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.67) | Quarterly Revenue Growth (0.82) | Return On Assets (1.29) | Return On Equity (8.88) |
The market value of Sellas Life Sciences is measured differently than its book value, which is the value of Sellas that is recorded on the company's balance sheet. Investors also form their own opinion of Sellas Life's value that differs from its market value or its book value, called intrinsic value, which is Sellas Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sellas Life's market value can be influenced by many factors that don't directly affect Sellas Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sellas Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sellas Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sellas Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Common Stock Total Equity Analysis
Compare Sellas Life Sciences and related stocks such as NLS Pharmaceutics, Mereo BioPharma Group, and Aravive Common Stock Total Equity Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NLSP | 128.3 K | 128.3 K | 128.3 K | 128.3 K | 128.3 K | 128.3 K | 128.3 K | 128.3 K | 133.5 K | 145.1 K | 145.1 K | 145.1 K | 145.1 K | 166.9 K | 151.8 K |
| MREO | 59.2 K | 59.2 K | 59.2 K | 59.2 K | 59.2 K | 59.2 K | 193 K | 213.3 K | 213.7 K | 294 K | 1 M | 1 M | 1 M | 1.2 M | 1.2 M |
| DAWN | 2 M | 2 M | 2 M | 2 M | 2 M | 2 M | 2 M | 2 M | 2 M | 2 M | 2 M | 6 K | 7 K | 6.3 K | 6 K |
| RVPHW | 618 | 618 | 618 | 618 | 618 | 618 | 618 | 618 | 618 | 618 | 923 | 923 | 923 | 1.1 K | 848 |
| EYEN | 227 | 227 | 227 | 227 | 227 | 227 | 227 | 257 | 1.1 K | 1.7 K | 2.5 K | 2.5 K | 2.5 K | 2.9 K | 3 K |
| CGTX | 29 K | 29 K | 29 K | 29 K | 29 K | 29 K | 29 K | 29 K | 29 K | 29 K | 29 K | 29 K | 29 K | 26.1 K | 23.2 K |
| RNAZ | 464 | 464 | 464 | 464 | 464 | 464 | 464 | 464 | 464 | 464 | 464 | 464 | 464 | 418 | 371 |
| KOD | 1000 | 1000 | 1000 | 1000 | 1000 | 1000 | 1000 | 1000 | 4 K | 5 K | 5 K | 5 K | 5 K | 5.8 K | 4.1 K |
| RVPH | 618 | 618 | 618 | 618 | 618 | 618 | 618 | 618 | 618 | 618 | 923 | 923 | 923 | 1.1 K | 848 |
| PLX | 588 | 86 K | 93 K | 93 K | 94 K | 100 K | 124 K | 144 K | 148 K | 15 K | 35 K | 35 K | 35 K | 40.2 K | 62.7 K |
| EYPT | 6.2 M | 21 K | 21 K | 23 K | 29 K | 29 K | 34 K | 39 K | 74 K | 109 K | 18 K | 34 K | 34 K | 30.6 K | 29.1 K |
| ENVB | 474.1 K | 121.4 K | 121.4 K | 121.4 K | 154.1 K | 118.7 K | 138.9 K | 181.6 K | 423.3 K | 25.2 K | 25.2 K | 25.2 K | 25.2 K | 22.7 K | 21.6 K |
| ELEV | 2 K | 2 K | 2 K | 2 K | 2 K | 2 K | 2 K | 2 K | 2 K | 2 K | 2 K | 2 K | 2 K | 1.8 K | 1.6 K |
| ANVS | 27.0 | 27.0 | 27.0 | 27.0 | 27.0 | 27.0 | 27.0 | 27.0 | 28.0 | 28.0 | 689 | 810 | 810 | 932 | 978 |
| SAVA | 9.4 K | 45 K | 45 K | 45 K | 46 K | 46 K | 46 K | 7 K | 17 K | 22 K | 35 K | 40 K | 40 K | 46 K | 39.3 K |
| AXSM | 769 | 769 | 769 | 769 | 1.1 K | 1.9 K | 1.9 K | 2.5 K | 3 K | 3.7 K | 3.7 K | 3.8 K | 3.8 K | 4.3 K | 2.7 K |
| MCRB | 7 K | 7 K | 7 K | 7 K | 7 K | 39 K | 40 K | 40 K | 41 K | 70 K | 91 K | 92 K | 125 K | 143.8 K | 150.9 K |
Sellas Life Sciences and related stocks such as NLS Pharmaceutics, Mereo BioPharma Group, and Aravive Common Stock Total Equity description
The total value of common stock equity held by shareholders, representing their ownership interest in the company.My Equities
My Current Equities and Potential Positions
Additional Tools for Sellas Stock Analysis
When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.